BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29024633)

  • 1. The Healthy and Diseased Microenvironments Regulate Oligodendrocyte Properties: Implications for Regenerative Medicine.
    Leferink PS; Heine VM
    Am J Pathol; 2018 Jan; 188(1):39-52. PubMed ID: 29024633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
    Armstrong RC; Mierzwa AJ; Sullivan GM; Sanchez MA
    Neuropharmacology; 2016 Nov; 110(Pt B):654-659. PubMed ID: 25963414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.
    Mühlebner A; van Scheppingen J; de Neef A; Bongaarts A; Zimmer TS; Mills JD; Jansen FE; Spliet WGM; Krsek P; Zamecnik J; Coras R; Blumcke I; Feucht M; Scholl T; Gruber VE; Hainfellner JA; Söylemezoğlu F; Kotulska K; Lagae L; Jansen AC; Kwiatkowski DJ; Jozwiak S; Curatolo P; Aronica E
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1054-1064. PubMed ID: 32954437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in white matter disorders of the CNS: mechanisms and therapeutic opportunities.
    Nutma E; Marzin MC; Cillessen SA; Amor S
    J Pathol; 2021 Feb; 253(2):133-147. PubMed ID: 33135781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can oligodendrocyte precursor cells be a therapeutic target for mitigating cognitive decline in cerebrovascular disease?
    Arai K
    J Cereb Blood Flow Metab; 2020 Aug; 40(8):1735-1736. PubMed ID: 32674700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Morphogenetic Proteins: Inhibitors of Myelination in Development and Disease.
    Grinspan JB
    Vitam Horm; 2015; 99():195-222. PubMed ID: 26279377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia.
    Zhang H; Yang Y; Zhang J; Huang L; Niu Y; Chen H; Liu Q; Wang R
    Neuroscience; 2024 Feb; 538():1-10. PubMed ID: 37913862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cells in the driver seat of leukodystrophy pathogenesis.
    Garcia LM; Hacker JL; Sase S; Adang L; Almad A
    Neurobiol Dis; 2020 Dec; 146():105087. PubMed ID: 32977022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.
    Choi BR; Kim DH; Back DB; Kang CH; Moon WJ; Han JS; Choi DH; Kwon KJ; Shin CY; Kim BR; Lee J; Han SH; Kim HY
    Stroke; 2016 Feb; 47(2):542-7. PubMed ID: 26670084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes.
    Nasrabady SE; Rizvi B; Goldman JE; Brickman AM
    Acta Neuropathol Commun; 2018 Mar; 6(1):22. PubMed ID: 29499767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
    Bugiani M; Postma N; Polder E; Dieleman N; Scheffer PG; Sim FJ; van der Knaap MS; Boor I
    Brain; 2013 Jan; 136(Pt 1):209-22. PubMed ID: 23365098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin, myelin-related disorders, and psychosis.
    Mighdoll MI; Tao R; Kleinman JE; Hyde TM
    Schizophr Res; 2015 Jan; 161(1):85-93. PubMed ID: 25449713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oligodendrocyte-neurovascular unit in white matter repair.
    Hamanaka G; Ohtomo R; Takase H; Lok J; Arai K
    Neurosci Lett; 2018 Sep; 684():175-180. PubMed ID: 30006018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?
    Schmitt A; Simons M; Cantuti-Castelvetri L; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):371-372. PubMed ID: 31076838
    [No Abstract]   [Full Text] [Related]  

  • 15. Astrocytes are central in the pathomechanisms of vanishing white matter.
    Dooves S; Bugiani M; Postma NL; Polder E; Land N; Horan ST; van Deijk AL; van de Kreeke A; Jacobs G; Vuong C; Klooster J; Kamermans M; Wortel J; Loos M; Wisse LE; Scheper GC; Abbink TE; Heine VM; van der Knaap MS
    J Clin Invest; 2016 Apr; 126(4):1512-24. PubMed ID: 26974157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Replacement Therapy Improves Pathological Hallmarks in a Mouse Model of Leukodystrophy Vanishing White Matter.
    Dooves S; Leferink PS; Krabbenborg S; Breeuwsma N; Bots S; Hillen AEJ; Jacobs G; van der Knaap MS; Heine VM
    Stem Cell Reports; 2019 Mar; 12(3):441-450. PubMed ID: 30799272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendrogenesis is differentially regulated in gray and white matter of jimpy mice.
    Baracskay KL; Duchala CS; Miller RH; Macklin WB; Trapp BD
    J Neurosci Res; 2002 Dec; 70(5):645-54. PubMed ID: 12424732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury in Mouse Brain.
    Li Y; Tang G; Liu Y; He X; Huang J; Lin X; Zhang Z; Yang GY; Wang Y
    Stem Cells Transl Med; 2015 Oct; 4(10):1122-30. PubMed ID: 26253714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin loss and oligodendrocyte pathology in white matter tracts following traumatic brain injury in the rat.
    Flygt J; Djupsjö A; Lenne F; Marklund N
    Eur J Neurosci; 2013 Jul; 38(1):2153-65. PubMed ID: 23458840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapy for white matter disorders: don't forget the microenvironment!
    Dooves S; van der Knaap MS; Heine VM
    J Inherit Metab Dis; 2016 Jul; 39(4):513-8. PubMed ID: 27000179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.